Story
Rapid7 Stock Slides After Morgan Stanley Downgrade Cites Competitive Threats
Summary
Shares of cybersecurity firm Rapid7 fell sharply after Morgan Stanley downgraded the stock to "Underweight," citing deteriorating fundamentals and increasing competition from AI-native rivals.
Shares of Rapid7 (NASDAQ: RPD) declined significantly in early trading after Morgan Stanley downgraded the cybersecurity provider to Underweight from Equalweight. The firm also established a new price target of $9.00, representing considerable downside from the stock's prior closing price of $11.95.
Analyst Cites Fundamental Challenges
Morgan Stanley's downgrade was rooted in what its analysts described as a "fundamental deterioration" in Rapid7's core vulnerability management business. The research note highlighted intensifying pressure from AI-native competitors who are gaining market share.
The firm pointed to Rapid7's anemic revenue growth as a key indicator of its struggles. According to the report, the company's sales grew by only 1.2% over the trailing twelve months, suggesting its strategic shift toward exposure management has not been successful in revitalizing performance.
Sector Rotation Amplifies Pressure
The downgrade was part of a broader reassessment of the cybersecurity sector by Morgan Stanley. The firm simultaneously upgraded competitor Fortinet to Equalweight and named Palo Alto Networks its new "Top Pick," signaling a preference for companies with stronger competitive positions.
AdThis sector-wide reshuffling created a relative rotation dynamic, where investors appeared to be reallocating capital to stronger cybersecurity names rather than exiting the industry altogether. The pressure on Rapid7 was exacerbated by a positive broader market, with both the Nasdaq and S&P 500 trading higher, underscoring the company-specific nature of the sell-off.
Market Outlook
While Morgan Stanley's action drove the negative sentiment, Truist Securities maintained its Hold rating on Rapid7 but raised its price target to $10.00 from $6.00. However, this modest revision was insufficient to counter the impact of the downgrade.
The consensus among analysts remains cautious, with an average rating of Hold. With the company's second-quarter earnings report not expected until August 10, Morgan Stanley's critical assessment is likely to shape investor sentiment in the near term.
Read next
More on Stocks
AutoZone Shares Jump as Strong Margins Outweigh Revenue Miss
The auto parts retailer reported fiscal fourth-quarter earnings that surpassed analyst expectations, driven by significant margin expansion, even as revenue fell short of forecasts for the fourth consecutive quarter.
Anthropic Launches Cheaper, Faster Claude 5.5 AI Model Ahead of Potential IPO
Anthropic has released its new flagship AI model, Claude Opus 5.5, which the company says is 40% cheaper and over 30% faster for enterprise use. The launch intensifies competition in the AI sector as the startup reportedly prepares for an initial public offering.
Bank of America Lifts Cybersecurity Price Targets on AI Threat Concerns
Bank of America has raised its price objectives for CrowdStrike, Okta, and SailPoint, citing growing investor recognition that artificial intelligence creates new security risks requiring significant investment. The cybersecurity sector has recently outperformed the broader market as the focus shifts to AI governance and threat mitigation.
AnaptysBio Stock Drops Despite Massive Q2 Earnings Beat as GSK Court Ruling Looms
AnaptysBio reported a significant earnings and revenue surprise for the second quarter, driven by strong Jemperli royalties. However, shares fell as investor attention remains fixed on the pending outcome of a key court case with partner GSK.